biocryst pharmaceuticals

Biocryst And 3DP Complement Agreement

BioCryst Pharmaceuticals, Inc. has transferred rights to specific classes of compounds that act as inhibitors of proteins and enzymes in the complement system to 3- Dimensional Pharmaceuticals, Inc. (3DP), a wholly owned subsidiary of Johnson & Johnson. BioCryst will receive an initial payment from 3DP, and will receive royalties on any future sales of complement Read more about Biocryst And 3DP Complement Agreement[…]

boston life sciences

Drug Delivery Device Supply Agreement For Boston Life Sciences And Codman & Shurtleff

Boston Life Sciences, Inc. has announced it has entered into an agreement with Codman & Shurtleff, Inc., a Johnson & Johnson subsidiary, related to BLSI’s development of Inosine for stroke. Under the agreement, Codman will supply BLSI with implantable pumps and catheters for BLSI’s preclinical and clinical studies for Inosine, and in exchange, Codman will Read more about Drug Delivery Device Supply Agreement For Boston Life Sciences And Codman & Shurtleff[…]

Photoelectron Announces Strategic Partnership With Cordis

Photoelectron Corporation has signed an exclusive agreement with Cordis Corporation, a Johnson & Johnson Company, to co-develop and co- manufacture a disposable miniature x-ray source and associated technology for the delivery of intravascular radiation therapy to prevent restenosis of coronary arteries following angioplasty and stent procedures. Cordis Corporation is a leader in circulatory disease management. Read more about Photoelectron Announces Strategic Partnership With Cordis[…]

Johnson &Johnson’s Epilepsy Drug Leads To Weight Loss

Johnson & Johnson have announced that obese patients lost over 11 percent of their body weight one year after being treated with the company’s anti-epilepsy drug Topamax.The firm is encouraged to continue developing the medicine as a weight-loss medicine.Topamax is currently approved only for treatment of epilepsy, but the New Brunswick, N.J.-based firm is also Read more about Johnson &Johnson’s Epilepsy Drug Leads To Weight Loss[…]

Buying Dragon Pharmaceuticals Legally

Trenbolone 200 - Bulk Price

Administration: Injection
Prime Ingredient: Trenbolone Enanthate
Manufacturer: Dragon Pharmaceuticals
Amount: 10 x 10 mL vial (200 mg/mL)
Price: 10 x $77.00

Tritren 150

Injectable Anabolic Steroid
Prime Ingredient: Trenbolones Blend
Produced by: Dragon Pharma Labs
Pack: 1 X 10 ml (150 mg/ml)

Turanabol - Bulk Price

Administration: Oral
Base Chemical Name: Chlorodehydromethyltestosterone
Manufacturer: Dragon Pharmaceuticals
Package: 10 x 100 tabs (10 mg/tablet)
Price: 10 x $70.00

Clenbuterol

Beta-2 Agonist, Bronchodilator
Principal Constituent: Clenbuterol Hydrochloride
Branded by: Dragon Pharma LLC
Unit: 1 X 100 tablets (40 mcg/tablet)

Cut Mix 150

Injectable Anabolic Steroid
Primary Constituent: Testosterone Propionate, Drostanolone Propionate, Trenbolone Acetate
Made by: Dragon Pharma Labs
Package: 1 X 10 ml (150 mg/ml)

Masteron 200

Injectable Anabolic Steroid
Prime Chemical Name: Drostanolone Enanthate
Manufacturer: Dragon Pharma
Amount: 1 X 10 ml (200 mg/ml)

EQ 300 [10 Vials]

Injectable Steroid for Muscle Growth
Active Chemical Name: Boldenone Undecylenate
Made by: Dragon Pharmaceutical
10 Vials [10 mL per Vial (300 mg/ml)]
Price: 10 x $42.00 = $420.00 in Total

Dianabol

Oral Steroid for Muscle Growth
Prime Substance: Methandrostenolone
Made by: Dragon Pharmaceutical
100 tablets (20 mg/pill)

Masteron 100

Injectable Steroid for Muscle Growth
Main Chemical Name: Drostanolone Di-Propionate
Made by: Dragon Pharmaceuticals
10 mL Sterile Multi-dose Vial (100 mg/mL)

Cut Mix 150

Active Substance: Testosterone Propionate,
Drostanolone Propionate, Trenbolone Acetate
Made by: Dragon Pharmaceuticals
Unit: 10 x 10 mL vial (150 mg/mL)

Trenbolone 200

Principal Ingredient: Trenbolone Enanthate
Manufacturer: Dragon Pharma
Pack: 10 mL vial (200 mg/mL)

TriTren 150

Basal Chemical Name: Tri Trenbolone
Producer: Dragon Pharma Labs
Pack: 10 mL vial (150 mg/mL)